Conformis CEO: Getting A Knee Up (Mad Money, CNBC)
Conformis is not responsible for the contents or reliability of any third-party materials accessible on Conformis’s website, including embedded videos, audio recordings and images, or links to external websites or other third-party materials. The information contained in such third-party materials may not be accurate or current, and Conformis does not necessarily endorse the views expressed within them. Any third-party materials are provided for your convenience and information only.
Conformis Announces FDA Clearance and Full Commercial Launch of Next Generation Hip System at the 2019 AAHKS Conference
Designed to enhance operational efficiency for the surgeon, the Conformis Hip System is the most advanced, patient-conforming hip replacement system
Conformis and Stryker Execute Development, License and Distribution Agreements
Deal to Cover Patient-Specific Instrumentation Used in Knee Arthroplasty BILLERICA, Mass., Oct. 01, 2019 (GLOBE NEWSWIRE) — Conformis, Inc. (NASDAQ: CFMS), a medical technology